A molecular and computational study of galbanic acid as a regulator of Sirtuin1 pathway in inhibiting lipid accumulation in HepG2 cells

References

• Afzaal, A., et al., 2022. Versatile role of sirtuins in metabolic disorders: from modulation of mitochondrial function to therapeutic interventions. Journal of biochemical and molecular toxicology, 36 (7), e23047. doi: 10.1002/jbt.23047.
   PubMed Web of Science ®Google Scholar
• Amalraj, A. and Gopi, S., 2017. Biological activities and medicinal properties of asafoetida: a review. Journal of traditional and complementary medicine, 7 (3), 347–359. doi: 10.1016/j.jtcme.2016.11.004.
   PubMedGoogle Scholar
• Avilkina, V., Chauveau, C., and Mhenni, O.G., 2022. Sirtuin function and metabolism: role in pancreas, liver, and adipose tissue and their crosstalk impacting bone homeostasis. Bone, 154, 116232. doi: 10.1016/j.bone.2021.116232.
   PubMed Web of Science ®Google Scholar
• Azminah, A., et al., 2019. In silico and in vitro identification of candidate SIRT1 activators from Indonesian medicinal plants compounds database. Computational biology and chemistry, 83, 107096. doi: 10.1016/j.compbiolchem.2019.107096.
   PubMed Web of Science ®Google Scholar
• Bakhshandeh, N., et al., 2022. Increased expression of androgen receptor and PSA genes in LNCaP (prostate cancer) cell line due to high concentrations of EGCG, an active ingredient in green tea. Hormone molecular biology and clinical investigation, 44 (2), 181–186. doi: 10.1515/hmbci-2022-0054.
   PubMed Web of Science ®Google Scholar
• Bitencourt-Ferreira, G. and Azevedo, W.F.D., 2019. Molegro Virtual Docker for docking. Methods in Molecular Biology, 2053, 149–167. doi: 10.1007/978-1-4939-9752-7_10.
   Google Scholar
• Brooks, B.R., et al., 2009. CHARMM: the biomolecular simulation program. Journal of computational chemistry, 30 (10), 1545–1614. doi: 10.1002/jcc.21287.
   PubMed Web of Science ®Google Scholar
• Curtis, W.M., et al., 2022. NADPH and mitochondrial quality control as targets for a circadian-based fasting and exercise therapy for the treatment of Parkinson’s disease. Cells, 11 (15), 2416. doi: 10.3390/cells11152416.
   PubMed Web of Science ®Google Scholar
• Dai, H., et al., 2010. SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. Journal of biological chemistry, 285 (43), 32695–32703. doi: 10.1074/jbc.M110.133892.
   PubMed Web of Science ®Google Scholar
• Dao, T.-T., et al., 2012. Terpenylated coumarins as SIRT1 activators isolated from Ailanthus altissima. Journal of natural products, 75 (7), 1332–1338. doi: 10.1021/np300258u.
   PubMed Web of Science ®Google Scholar
• De Gregorio, E., et al., 2020. Relevance of SIRT1–NF-κB axis as therapeutic target to ameliorate inflammation in liver disease. International journal of molecular sciences, 21 (11), 3858. doi: 10.3390/ijms21113858.
   PubMed Web of Science ®Google Scholar
• Ezhilarasan, D. and Najimi, M., 2021. Role of sirtuins in liver diseases. In: Sirtuin biology in medicine (pp. 329–340). Academic Press. doi: 10.1016/B978-0-12-814118-2.00005-7.
   Google Scholar
• Fernández-Quintela, A., et al., 2017. Antiobesity effects of resveratrol: which tissues are involved? Annals of the New York academy of sciences, 1403 (1), 118–131. doi: 10.1111/nyas.13413.
   PubMed Web of Science ®Google Scholar
• Gliszczyńska, A. and Brodelius, P.E., 2012. Sesquiterpene coumarins. Phytochemistry reviews, 11 (1), 77–96. doi: 10.1007/s11101-011-9220-6.
   Web of Science ®Google Scholar
• Huang, J. and MacKerell, A.D., Jr., 2013. CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. Journal of computational chemistry, 34 (25), 2135–2145. doi: 10.1002/jcc.23354.
   PubMed Web of Science ®Google Scholar
• Kim, S., et al., 2016. PubChem substance and compound databases. Nucleic acids research, 44 (D1), D1202–D1213. doi: 10.1093/nar/gkv951.
   PubMed Web of Science ®Google Scholar
• Kim, S.C., et al., 2015. Fisetin induces Sirt1 expression while inhibiting early adipogenesis in 3T3-L1 cells. Biochemical and biophysical research communications, 506 (1), 306–644. doi: 10.1016/j.bbrc.2018.10.068.
   Google Scholar
• Kouranov, A., et al., 2006. The RCSB PDB information portal for structural genomics. Nucleic acids research, 34 (Database issue), D302–D305. doi: 10.1093/nar/gkj120.
   PubMedGoogle Scholar
• Lee, D.E., et al., 2019. Curcumin ameliorates nonalcoholic fatty liver disease through inhibition of O-GlcNAcylation. Nutrients, 11 (11), 2702. doi: 10.3390/nu11112702.
   PubMed Web of Science ®Google Scholar
• Lindahl, Abraham, Hess, Spoel, V.D., 2020. GROMACS 2020.1 source code. Zenodo. doi: 10.5281/zenodo.3685919.
   Google Scholar
• Mahita, J. and Sowdhamini, R., 2018. Investigating the effect of key mutations on the conformational dynamics of toll-like receptor dimers through molecular dynamics simulations and protein structure networks. Proteins, 86 (4), 475–490. doi: 10.1002/prot.25467.
   PubMed Web of Science ®Google Scholar
• Musavi, H., et al., 2023. Galbanic acid of Ferula assa-foetida L, as a regulator of the AMPK pathway in reduction of lipid accumulation in HepG2 cells. Immunopathologia persa, 9 (2), 39479.
   Web of Science ®Google Scholar
• Namvarjah, F., et al., 2022. Chlorogenic acid improves anti-lipogenic activity of metformin by positive regulating of AMPK signaling in HepG2 cells. Cell biochemistry and biophysics, 80 (3), 537–545. doi: 10.1007/s12013-022-01077-1.
   PubMed Web of Science ®Google Scholar
• Park, S.-J., et al., 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell, 148 (3), 421–433. doi: 10.1016/j.cell.2012.01.017.
   PubMed Web of Science ®Google Scholar
• Peng, Z., et al., 2018. Nobiletin alleviates palmitic acid‑induced NLRP3 inflammasome activation in a sirtuin 1‑dependent manner in AML‑12 cells. Molecular medicine reports, 18 (6), 5815–5822. doi: 10.3892/mmr.2018.9615.
   PubMed Web of Science ®Google Scholar
• Risitano, R., et al., 2014. Flavonoid fraction of bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes. PLOS one, 9 (9), e107431. doi: 10.1371/journal.pone.0107431.
   PubMed Web of Science ®Google Scholar
• Sadeghkhani, F., Hajihassan, Z., and Gharaghani, S., 2022. Identification of new potent agonists for toll-like receptor 8 by virtual screening methods, molecular dynamics simulation, and MM-GBSA. Journal of biomolecular structure & dynamics, 41 (19), 10026–10036. doi: 10.1080/07391102.2022.2152368.
   PubMed Web of Science ®Google Scholar
• Sanner, M. F., Stoffler, D., and Olson, A.J., 2002. ViPEr, a visual programming environment for Python. In: Proceedings of the 10th international python conference, Jaiper, India, 13–15 October 2017. 103–115.
   Google Scholar
• Sayed, A.M., et al., 2020. Flavonoids-mediated SIRT1 signaling activation in hepatic disorders. Life sciences, 259, 118173. doi: 10.1016/j.lfs.2020.118173.
   PubMed Web of Science ®Google Scholar
• Shentu, T.-P., et al., 2016. AMP-activated protein kinase and sirtuin 1 coregulation of cortactin contributes to endothelial function. Arteriosclerosis, thrombosis, and vascular biology, 36 (12), 2358–2368. doi: 10.1161/ATVBAHA.116.307871.
   PubMed Web of Science ®Google Scholar
• Sonigra, P. and Meena, M., 2020. Metabolic profile, bioactivities, and variations in the chemical constituents of essential oils of the Ferula genus (Apiaceae). Frontiers in pharmacology, 11, 608649. doi: 10.3389/fphar.2020.608649.
   PubMed Web of Science ®Google Scholar
• Sun, Y., et al., 2018. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21. British journal of pharmacology, 175 (2), 374–387. doi: 10.1111/bph.14079.
   PubMed Web of Science ®Google Scholar
• Trott, O. and Olson, A.J., 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry, 31 (2), 455–461. doi: 10.1002/jcc.21334.
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., et al., 2010. CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields. Journal of computational chemistry, 31 (4), 671–690. doi: 10.1002/jcc.21367.
   PubMed Web of Science ®Google Scholar
• Wang, G.-L., et al., 2009. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1–FOXO1 signaling pathway. Biochemical and biophysical research communications, 380 (3), 644–649. doi: 10.1016/j.bbrc.2009.01.163.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2022. Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8. PLOS one, 17 (4), e0260565. doi: 10.1371/journal.pone.0260565.
   PubMed Web of Science ®Google Scholar
• Wu, Y., et al., 2020. A review on anti-tumor mechanisms of coumarins. Frontiers in oncology, 10, 592853. doi: 10.3389/fonc.2020.592853.
   PubMed Web of Science ®Google Scholar
• Yamazaki, Y., et al., 2009. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. American journal of physiology. Endocrinology and metabolism, 297 (5), E1179–E1186. doi: 10.1152/ajpendo.90997.2008.
   PubMed Web of Science ®Google Scholar
• Ye, Y., et al., 2022. Water extract of Ferula lehmanni Boiss. prevents high-fat diet-induced overweight and liver injury by modulating the intestinal microbiota in mice. Food & function, 13 (3), 1603–1616. doi: 10.1039/d1fo03518e.
   PubMed Web of Science ®Google Scholar
• Yu, N.-D., et al., 2022. A novel mechanism for SIRT1 activators that does not rely on the chemical moiety immediately C-terminal to the acetyl-lysine of the substrate. Molecules, 27 (9), 2714. doi: 10.3390/molecules27092714.
   PubMed Web of Science ®Google Scholar
• Yu, W., et al., 2012. Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations. Journal of computational chemistry, 33 (31), 2451–2468. doi: 10.1002/jcc.23067.
   PubMed Web of Science ®Google Scholar
• Zeng, C. and Chen, M., 2022. Progress in nonalcoholic fatty liver disease: SIRT family regulates mitochondrial biogenesis. Biomolecules, 12 (8), 1079. doi: 10.3390/biom12081079.
   PubMed Web of Science ®Google Scholar
• Zia, A., et al., 2021. A review study on the modulation of SIRT1 expression by miRNAs in aging and age-associated diseases. International journal of biological macromolecules, 188, 52–61. doi: 10.1016/j.ijbiomac.2021.08.013.
   PubMed Web of Science ®Google Scholar